Xellia Pharmaceuticals receives FDA approval of injectable manufacturing site in Bedford

Since its 2015 acquisition of the former Ben venue Laboratories site in Bedford, Xellia has invested to create a modern facility that will allow the company to continue to provide a reliable and consistent supply of its anti-infective products across the Unites States. Xellia took over the facility in 2015 after receiving a tax credit under Ohio’s Job Creation Tax Credit program.

Click here to read the complete story.

Story excerpt provided by Crain’s Cleveland Business.

Written by Lydia Coutre.

Originally published March 30, 2020.